# Efficacy and Safety of a Probiotic Composition as Adjunct in MAFL Management

> **NCT04823676** · NA · COMPLETED · sponsor: **AB Biotics, SA** · enrollment: 100 (actual)

## Conditions studied

- Non Alcoholic Fatty Liver

## Interventions

- **DIETARY_SUPPLEMENT:** Probiotic composition
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04823676
- **Lead sponsor:** AB Biotics, SA
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-31
- **Primary completion:** 2021-12-13
- **Final completion:** 2022-02-22
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2022-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04823676

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04823676, "Efficacy and Safety of a Probiotic Composition as Adjunct in MAFL Management". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04823676. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*